Bio-Gene Technology Limited (ASX:BGT)
Australia · Delayed Price · Currency is AUD 0.0210
0.00 (0.00%)
Aug 14, 2025, 4:10 PM AEST
Bio-Gene Technology Market Cap
Bio-Gene Technology has a market cap or net worth of 6.41 million as of August 14, 2025. Its market cap has decreased by -38.82% in one year.
Market Cap
6.41M
Enterprise Value
5.07M
Revenue
-435.00
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 29, 2017, Bio-Gene Technology's market cap has decreased from 20.89M to 6.41M, a decrease of -69.34%. That is a compound annual growth rate of -14.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 6.41M | -26.01% |
| Dec 30, 2024 | 8.66M | -28.33% |
| Dec 29, 2023 | 12.08M | -32.09% |
| Dec 29, 2022 | 17.79M | -48.81% |
| Dec 31, 2021 | 34.76M | 61.59% |
| Dec 31, 2020 | 21.51M | -19.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.74B |
| Pro Medicus | 31.67B |
| Cochlear | 20.37B |
| Sonic Healthcare | 13.83B |
| Ramsay Health Care | 8.87B |
| Telix Pharmaceuticals | 5.72B |
| Ansell | 4.51B |
| Mesoblast | 2.93B |